Director Catherine E. Woteki filed a Form 4 with the SEC on October 30, 2026, disclosing the vesting and settlement of 1,776 restricted stock units into an equal number of Neogen Corp common shares on October 29, 2026.

Key Highlights

  • Reporting person: Catherine E. Woteki, Director of Neogen Corp (NASDAQ:NEOG)
  • Transaction date: October 29, 2026, with the filing submitted October 30, 2026
  • RSUs vested and settled: 1,776 restricted stock units converted into 1,776 shares of common stock at a price of $12.21
  • Transaction code: M (exercise or conversion of derivative security)
  • Remaining RSUs: 0 derivative securities beneficially owned following the transaction
  • Resulting direct ownership: 29,507 shares of common stock held directly after the transaction

Woteki RSU Vesting Details for Neogen Corp

According to the filing, Catherine E. Woteki, a director of Neogen Corp, reported the vesting and settlement of restricted stock units on October 29, 2026. The filing states that "each RSU is the economic equivalent of one share of common stock" and that "on October 29, 2026, these RSUs vested and were settled for an equal number of shares of common stock." The transaction is recorded under code M, indicating conversion of a derivative security.

The filing discloses that 1,776 RSUs were acquired as common stock (code A) at a price of $12.21 per unit in Table I, reflecting the settlement of the derivative position reported in Table II. Following the transaction, Woteki's direct beneficial ownership in Neogen Corp common stock stands at 29,507 shares, according to the filing. The derivative security position, listed in Table II as restricted stock units with a conversion price of $12.21, shows 0 units remaining after the settlement.

The form was signed by Christopher Sefcheck as attorney in fact and dated October 30, 2026. The date of earliest transaction is listed in the filing as October 1, 2026. No amendment date is indicated, and the filing was made by one reporting person.

What Was Disclosed

Neogen Corp director Catherine E. Woteki disclosed the vesting of 1,776 RSUs into an equal number of common shares on October 29, 2026, at $12.21, leaving her with direct ownership of 29,507 shares and zero remaining RSUs.